Rubicon Research Private Limited, a a portfolio company of General Atlantic, has acquired Concord, Ontario-based Impopharma, a development and testing facility specializing in pulmonary and nasal drug ...
MUMBAI, India — As part of its ongoing effort to establish a global development network, Rubicon Research Private Limited, a leading specialty pharmaceutical company, today announced the acquisition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results